TP53 and breast cancer: More specifically, we ranked 799 miRNAs that were differentially expressed between the 64 wild-type samples and 36 TP53 mutant breast cancer samples collected from [39] via CyREST API called in R environment using the miRNA-target gene network constructed from miRWalk [35] and the known disease-miRNA association dataset HMDD [38].